Abstract:In this study, a Monte Carlo simulation of hepatic steatosis was developed to predict R2* and PDFF. Furthermore, effects of fat droplet morphology, fat susceptibility, fat signal model and magnetic field strength were evaluated for R2* ‐PDFF calibration. Results suggest that Monte Carlo simulations provide a new means for R2* ‐PDFF prediction, and this means can be easily generated for various regimes, for example, simulations with higher fields and different echo times, as well as correction of magnetic susceptibility measurements for iron quantification. To develop Monte Carlo simulations to predict the relationship of R2* with liver fat content at 1.5 T and 3.0 T. For various fat fractions (FFs) from 1% to 25%, four types of virtual liver models were developed by incorporating the size and spatial distribution of fat droplets. Magnetic fields were then generated under different fat susceptibilities at 1.5 T and 3.0 T, and proton movement was simulated for phase accrual and MRI signal synthesis. The synthesized signal was fit to single‐peak and multi‐peak fat signal models for R2* and proton density fat fraction (PDFF) predictions. In addition, the relationships between R2* and PDFF predictions were compared with in vivo calibrations and Bland–Altman analysis was performed to quantitatively evaluate the effects of these components (type of virtual liver model, fat susceptibility, and fat signal model) on R2* predictions. A virtual liver model with realistic morphology of fat droplets was demonstrated, and R2* and PDFF values were predicted by Monte Carlo simulations at 1.5 T and 3.0 T. R2* predictions were linearly correlated with PDFF, while the slope was unaffected by the type of virtual liver model and increased as fat susceptibility increased. Compared with in vivo calibrations, the multi‐peak fat signal model showed superior performance to the single‐peak fat signal model, which yielded an underestimation of liver fat. The R2* ‐PDFF relationships by simulations with fat susceptibility of 0.6 ppm and the multi‐peak fat signal model were R2*=0.490×PDFF+28.0 (R2=0.967 , p<0.01 ) at 1.5 T and R2*=0.928×PDFF+39.4 (R2=0.972 , p<0.01 ) at 3.0 T. Monte Carlo simulations provide a new means for R2* ‐PDFF prediction, which is primarily determined by fat susceptibility, fat signal model, and magnetic field strength. Accurate R2* ‐PDFF calibration has the potential to correct the effect of fat on R2* quantification, and may be helpful for accurate R2* measurements in liver iron overload. In this study, a Monte Carlo simulation of hepatic steatosis was developed to predict the relationship between R2* and PDFF. Furthermore, the effects of fat droplet morphology, fat susceptibility, fat signal model, and magnetic field strength were evaluated for the R2* ‐PDFF calibration. Our results suggest that Monte Carlo simulations provide a new means for R2* ‐PDFF prediction and this means can be easily generated for various regimes, such as simulations with higher fields and different echo times, as well as correction of magnetic susceptibility measurements for liver iron quantification.

Stong Cyclic Planning Under Partial Observability

Improved liver fat and R2* quantification at 0.55 T using locally low‐rank denoising

Free-breathing liver fat quantification using a multiecho 3D stack-of-radial technique.

Accelerated K‐space Shift Calibration for Free‐breathing Stack‐of‐radial MRI Quantification of Liver Fat And

Confidence maps for reliable estimation of proton density fat fraction and R2* in the liver

Free‐breathing Multitasking Multi‐echo MRI for Whole‐liver Water‐specific T1, Proton Density Fat Fraction, and Quantification

Comparative analysis of hepatic fat quantification across 5 T, 3 T and 1.5 T: A study on consistency and feasibility

Prediction of MRI R2* relaxometry in the presence of hepatic steatosis by Monte Carlo simulations

Liver Fat Content Measurement with Quantitative CT Validated Against MRI Proton Density Fat Fraction: A Prospective Study of 400 Healthy Volunteers.

Accelerated free‐breathing liver fat and R2* quantification using multi‐echo stack‐of‐radial MRI with motion‐resolved multidimensional regularized reconstruction: Initial retrospective evaluation

R2* Impact on Hepatic Fat Quantification With a Commercial Single Voxel Technique at 1.5 and 3.0 T

MRI Dixon Fat-Corrected Look-Locker T1 Mapping for Quantification of Liver Fibrosis and Inflammation—A Comparison With the Non–Fat-Corrected Shortened Modified Look-Locker Inversion Recovery Technique

Context Information-based Application Access Control Model

Hyperpolarized 13C metabolic imaging of the human abdomen with spatiotemporal denoising

Fast multi-parametric imaging in abdomen by B1+corrected dual-flip angle sequence with interleaved echo acquisition

Noise‐reduction techniques for 1H‐FID‐MRSI at 14.1 T: Monte Carlo validation and in vivo application

Comparison of reader agreement, correlation with liver biopsy, and time-burden sampling strategies for liver proton density fat fraction measured using magnetic resonance imaging in patients with obesity: a secondary cross-sectional study

Noise-reduction techniques for 1H-FID-MRSI at 14.1T: Monte-Carlo validation & in vivo application

Pilot tone-guided focused navigation for free-breathing whole-liver fat-water and T2* quantification

Comparison of Vendor-Independent Software Tools for Liver Proton Density Fat Fraction Estimation at 1.5 T

Ultrasound-Derived Fat Fraction for Hepatic Steatosis Assessment: Prospective Study of Agreement With MRI PDFF and Sources of Variability in a Heterogeneous Population